A newly discovered set of salivary glands could have implications for protecting head and neck cancer patients from radiation side effects, and younger melanoma patients respond better to a targeted therapy than older patients.

by Kate Yandell

A study finds that some commercially insured patients getting screening colonoscopies receive a bill for out-of-network services, and a machine learning algorithm helps nudge oncology clinicians to talk about prognosis and the end of life.

by Kate Yandell

A study finds that more than half of cancer patients participate in clinical trials when asked, and an annual survey sheds light on cancer patients' experience of the coronavirus pandemic.

by Kate Yandell

A study finds that human papillomavirus vaccination reduces the rate of cervical cancer, and pediatric cancer researchers identify tradeoffs between reducing recurrence risk and minimizing long-term effects of treatment.

by Kate Yandell

A trial shows that a form of targeted chemotherapy lengthens life for people with metastatic, triple-negative breast cancer, and researchers release more data on targeting KRAS-mutated lung cancer.

by Kate Yandell

A report finds that more progress is needed to reduce cancer health disparities, and a study indicates that drinking large amounts of coffee may slightly lengthen survival for people with advanced or metastatic colorectal cancer.

by Kate Yandell

Doctors and researchers point out that instructions on scalp cooling were not formulated with Black patients in mind, and the Food and Drug Administration approves a targeted therapy for lung cancer.

by Kate Yandell

A study finds that personal use of permanent hair dye is generally not associated with increased cancer risk, and Chadwick Boseman's death starts conversations about early-onset colorectal cancer.

by Kate Yandell

ESMO issues guidance about biomarker testing, researchers break down coronavirus risk by cancer type, and the FDA approves liquid biopsy test across tumor types.

by Marci A. Landsmann

A combination of targeted therapies may be effective in people with bile duct cancers, and recent chemotherapy is not associated with worse outcomes from COVID-19.

by Kate Yandell